Lab Developed Tests

Join Today's Clinical Lab and our experts for our Blood & Clinical Chemistry Digital Forum on October 21, 2026

Oversight of the laboratory testing field must balance safety with speed and innovation

The innovative capabilities of LDTs should endure as long as the field remains data-driven, standards-compliant, and committed to continuous quality improvement

What steps should your lab take in response to shifting LDT oversight?

Join Today's Clinical Lab and a panel of regulatory and industry experts as they explore what’s ahead in laboratory compliance—and what labs need to know right now

Anthony Killeen reacts to news that influential committee has been dismantled by the US federal government

AMP President Jane S. Gibson, PhD, affirms the court ruling calling it a win for patients, innovation, and molecular pathology 

Prior to the MSDA Test, disease management in MS relied primarily on clinical assessments and MRI

VeraBIND™ Tau is a new noninvasive test that offers 96 percent sensitivity and 90 percent specificity, empowering earlier and more accessible Alzheimer's detection

Under the district court’s vacatur, the LDT final rule and its compliance deadlines are no longer in effect and cannot be enforced